跳至主要内容
临床试验/NCT01417234
NCT01417234已完成不适用

Post-Market Clinical Evaluation of the Spiracur SNaP Wound Care System for Treatment of Acute Trauma and Acute Surgical Excision Wounds

3M1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2011年6月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
3M
入组人数
30
试验地点
1
主要终点
Wound Closure

研究概览

简要总结

The purpose of this study is to evaluate the efficacy of the Spiracur SNaP® Wound Care System for the treatment of acute trauma and acute surgical excision wounds. The secondary purpose will be to compare the prospective patients to retrospectively treated acute trauma wounds to further evaluate efficacy and safety.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Trauma wound, pressure ulcer, post operative wound, colostomy take-down site, or other acute wound deemed appropriate by study investigator(s) as the source of the wound on any part of the body including head and neck, torso, and extremities
  • Wound < 16 cm in greatest diameter
  • Subject ≥ 18 years of age
  • Exudate < 25 ml/ day (estimate)
  • Female subjects of child-bearing potential must be willing to take a urine pregnancy test prior to starting study
  • Subject is willing and able to sign informed consent

排除标准

  • Wound > 45 days old
  • Wound-related cellulitis
  • Wound located in an area not amenable to forming an air-tight seal
  • Subject has untreated osteomyelitis
  • Subject is allergic to wound care products
  • Wound has exposed blood vessels not suitable for negative pressure therapy
  • Subject is pregnant
  • Subject is actively participating in other clinical trials that conflict with current study
  • Subject has fistulas

结局指标

主要结局

Wound Closure

时间窗: 12 weeks

Percent of subjects with study wound deemed closed at 12 weeks 1 wound is studied per participant

次要结局

  • Percent Wound Size Change(8 weeks and 12 weeks)

研究者

发起方
3M
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Post-Market Clinical Evaluation of the Spiracur SNaP... | 临床试验